High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6 11 16 18 L1 virus-like particle vaccine through 5 years of follow-up

Villa, L L ; Costa, R L R ; Petta, C A ; Andrade, R P ; Paavonen, J ; Iversen, O-E ; Olsson, S-E ; Høye, J ; Steinwall, M ; Riis-Johannessen, G ; Andersson-Ellstrom, A ; Elfgren, K ; Krogh, G von ; Lehtinen, M ; Malm, C ; Tamms, G M ; Giacoletti, K ; Lupinacci, L ; Railkar, R ; Taddeo, F J ; Bryan, J ; Esser, M T ; Sings, H L ; Saah, A J ; Barr, E

British journal of cancer, 2006-12, Vol.95 (11), p.1459-1466 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível